EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Multizentrische StudieVergleichsstudieOpen Access

Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma

Shaji Kumar iD, Susanna Jacobus, Adam Cohen, Matthias Weiss, Natalie Callander, Avina Singh, Terri Parker, Michael Green, Raymond Thertulien, Benjamin Parsons, Pankaj Kumar, Prashant Kapoor und 12 weitere

New England Journal of Medicine · 16.07.2026 · 395 (3) · 221-232

DOI: 10.1056/nejmoa2600157 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 16.07.2026. Verfasst von Shaji Kumar und 23 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic, Rochester, MN. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Lenalidomide, Maintenance Chemotherapy, Multiple Myeloma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Combined Chemotherapy ProtocolsLenalidomideMaintenance ChemotherapyMultiple MyelomaNeoplasms, Second PrimaryAdultAgedFemaleHumansMaleMiddle AgedDrug Administration ScheduleKaplan-Meier EstimateDisease ProgressionProteasome InhibitorsTime FactorsProgression-Free SurvivalIncidenceBortezomibOligopeptidesDexamethasoneFollow-Up Studies

Substanzen

LenalidomideProteasome InhibitorsBortezomibcarfilzomibOligopeptidesDexamethasone

Autor:innen und Institutionen

  • Mayo Clinic, Rochester, MN.
  • ECOG-ACRIN Biostatistics Center, Boston.
  • University of Pennsylvania, Philadelphia.
  • ThedaCare Regional Medical Center, Appleton, WI.
  • University of Wisconsin, Madison.
  • Fairview Ridges Hospital, Burnsville, MN.

ORCID-Profile: Shaji Kumar, Aaron Rosenberg

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Kumar, S., Jacobus, S., Cohen, A., Weiss, M., Callander, N., Singh, A., Parker, T., Green, M., Thertulien, R., Parsons, B., Kumar, P., Kapoor, P., Rosenberg, A., Dib, E., Almquist, D., Zonder, J., Faber, E., Wei, Z., Anderson, K., …, & Rajkumar, S. V. (2026). Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma. New England Journal of Medicine, 395(3), 221-232. https://doi.org/10.1056/nejmoa2600157

Vancouver

Kumar S, Jacobus S, Cohen A, Weiss M, Callander N, Singh A, et al. Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma. New England Journal of Medicine. 2026;395(3):221-232. doi:10.1056/nejmoa2600157

BibTeX
@article{Kumar2026,
  author = {Kumar, Shaji and Jacobus, Susanna and Cohen, Adam and Weiss, Matthias and Callander, Natalie and Singh, Avina and Parker, Terri and Green, Michael and Thertulien, Raymond and Parsons, Benjamin and Kumar, Pankaj and Kapoor, Prashant and Rosenberg, Aaron and Dib, Elie and Almquist, Daniel and Zonder, Jeffrey and Faber, Edward and Wei, Zihan and Anderson, Kenneth and Lonial, Sagar and Richardson, Paul and Orlowski, Robert and Wagner, Lynne and Rajkumar, S Vincent},
  title = {Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma},
  journal = {New England Journal of Medicine},
  year = {2026},
  volume = {395},
  number = {3},
  pages = {221--232},
  doi = {10.1056/nejmoa2600157}
}
Kostenlos starten →